Transcatheter Aortic Valve Implantation in a 60-Years-Old Chronic Lymphocytic Leukemia Patient with a Right Bundle Branch Block
DOI:
https://doi.org/10.5281/zenodo.14572388Abstract
Aortic stenosis (AS) is a prevalent condition in the elderly population that can have severe consequences. Transcatheter Aortic Valve Implantation (TAVI) has emerged as an effective alternative treatment for elderly individuals with symptomatic severe AS and high surgical risk. However, the efficacy of TAVI in the presence of malignancy remains controversial. This case report presents a TAVI procedure performed on a 60-year-old patient with chronic lymphocytic leukemia (CLL), right bundle branch block (RBBB), and symptomatic severe AS. The patient's condition, comorbidities, and life expectancy were thoroughly evaluated by a multidisciplinary team, leading to the decision to proceed with TAVI. The procedure was performed successfully without complications, and the patient's 30-day outcomes were uneventful.
References
Smith CR, Leon M, Mack MJ, et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med 2011; 364:2187-2198 DOI: 10.1056/NEJMoa1103510.
The UK TAVI Trial Investigators. Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial. JAMA. 2022;327(19):1875–1887. doi:10.1001/jama.2022.5776.
Fecher MA, Birdas TJ, Haybron D, et al. Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg 2004; 25(4):537-40. doi: 10.1016/j.ejcts.2003.12.006.
Leon MB, Mack MJ, Hahn RT, et al. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. J Am Coll Cardiol. 2021, 77 (9): 1149–1161.
Sari C, Ayhan H, Bastug S, Turk Kardiyol Dern Ars 2015;43(6):529-35. doi: 10.5543/tkda.2015.99442.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Advances in Cardiac Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
